Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending June 2012. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific director transaction and does not contain financial statements or performance metrics.
Material Changes
No material changes to the company's financial position or operations are reported in this document. The only change noted is the acquisition of shares by a connected person.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, risks, contingencies, or unusual items. It strictly details a compliance notification under Disclosure and Transparency Rule 3.1.4R(1)(c).
Important Facts for Investors
- Transaction Date: June 13, 2012.
- Connected Person: Mrs. K Thomson (connected to Director Mr. P C Thomson).
- Transaction Details: Acquisition of 4 Ordinary Shares total (2 via personal contribution, 2 via company matching contribution) under the ShareReward Plan.
- Share Price: 1460.47 pence per Ordinary Share.
- Notification Date: June 14, 2012.